Genmab: 2Q Sales of Leukemia Drug Arzerra Totaled GBP12.8 Million
July 23 2014 - 6:50AM
Dow Jones News
By Dominic Chopping
Danish pharmaceutical company Genmab A/S (GEN.KO) said Wednesday
that net sales of leukemia drug Arzerra (ofatumumab) during the
second quarter of 2014 were GBP12.8 million.
This figure consists of net sales in the US of GBP6.9 million
and in the rest of the world of GBP5.9 million.
Under the terms of the collaboration with GlaxoSmithKline (GSK),
Genmab expects to receive a royalty payment of approximately DKK23
million.
The second quarter net sales did not include sales related to
the supply of ofatumumab for clinical trials run by other
parties.
-Write to Dominic Chopping at dominic.chopping@wsj.com; Twitter:
@WSJNordics
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
GSK (NYSE:GSK)
Historical Stock Chart
From May 2023 to May 2024